News
ImmuCell Corporation Announces Pricing of $9.0 Million Public Offering of Common Stock
PORTLAND, Maine, March 27, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Commencement of Public Offering of Common Stock
PORTLAND, Maine, March 26, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Submission of Manufacturing Technical Section for its Purified Nisin Product
PORTLAND, Maine, Feb. 28, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018
PORTLAND, Maine, Feb. 13, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2018
Conference Call Scheduled for Thursday, February 14, 2019 at 9:00 AM ET PORTLAND, Maine, Feb. 06, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces USDA Approval of Dual-Force™ First Defense®
PORTLAND, Maine, Dec. 11, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for Third Quarter of 2018
PORTLAND, Maine, Nov. 13, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Participate at 9th Annual Craig-Hallum Alpha Select Conference
PORTLAND, Maine, Nov. 08, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Third Quarter of 2018
Conference Call Scheduled for Wednesday, November 14, 2018 at 9:00 AM ET PORTLAND, Maine, Nov. 07, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces Issuance of Human Food Safety Technical Section Complete Letter for its Purified Nisin Product
PORTLAND, Maine, Sept. 25, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...